Corporate Business Development - QIAGEN

Commercial opportunities

To continue to meet and exceed customer expectations in our developing commercial markets, QIAGEN plans to optimize and diversify its technology interests in the following areas:

• Novel technologies for handling and preparing samples prior to analysis of nucleic acids and proteins
• Fractionation, enrichment, and depletion technologies
  
• Storage, retrieval, and transportation solutions
• Amplification technologies
• Enzymes for molecular biology applications
• Molecular testing, clinical research, and diagnostics using nucleic acids
• Gene expression at the RNA and protein level
• Digital PCR applications and related technologies
• Technologies and reagents related to next generation sequencing
• Digital pathology
• Digital cytology
• Diagnosis of immune related diseases
• Omics knowledge
• Bioinformatics software and analysis tools
• Omics relevant Data Science and AI capabilities
• Clinical decision support software, data and services
• General molecular biology research

QIAGEN believes that innovation occurs anywhere that humans are solving problems that make improvements in life possible. We recognize that the diverse ingenuity of individuals, regardless of age, educational background, gender, nationality, physical abilities, race, ethnic background, or religion, is a foundation for successful innovation in our workplace and products. Consequently QIAGEN welcomes the opportunity to consider business partnerships with organizations that strive to achieve better sample to insight solutions, regardless of their size or global location.